Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Original Research
A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany
Ann-Cathrine Siefena VITIS Healthcare Group, Cologne, Germany
https://orcid.org/0009-0002-3246-1461View further author information
https://orcid.org/0009-0002-3246-1461View further author information, Melina Sophie Kurtea VITIS Healthcare Group, Cologne, Germany;b Faculty of Medicine, University of Duisburg-Essen, Essen, Germanyhttps://orcid.org/0009-0006-8918-1769View further author information
https://orcid.org/0009-0006-8918-1769View further author information, , Oliver A. Cornelyc Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;d Center for Integrated Oncology (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;e Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany;f Institute of Translational Research, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany;g Excellence Centre for Medical Mycology (ECMM), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germanyhttps://orcid.org/0000-0001-9599-3137View further author information
https://orcid.org/0000-0001-9599-3137View further author information, Sebastian Wingen-Heimanna VITIS Healthcare Group, Cologne, Germany;c Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;d Center for Integrated Oncology (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;h Competence Center for Medical Economy, FOM University of Applied Sciences, Essen, Germanyhttps://orcid.org/0000-0002-4232-6944View further author information
https://orcid.org/0000-0002-4232-6944View further author information & Florian Krona VITIS Healthcare Group, Cologne, Germany;c Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;d Center for Integrated Oncology (CIO ABCD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany;h Competence Center for Medical Economy, FOM University of Applied Sciences, Essen, GermanyCorrespondence[email protected]
https://orcid.org/0000-0003-4907-7490View further author information
https://orcid.org/0000-0003-4907-7490View further author information